Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.
Press releases published on June 17, 2025
AMERICAN SALARS COMPLETES SAMPLING AT BRAZILIAN LCT PEGMATITE PROJECT
GlobeNewswire
·
June 17, 2025
VANCOUVER, BC, June 17, 2025 (GLOBE NEWSWIRE) -- AMERICAN SALARS LITHIUM INC. ("AMERICAN SALARS" OR THE "COMPANY") (CSE: USLI, OTC: USLIF, FWB: Z3P, WKN: A3E2NY) announces that it has now completed a second sampling program on its 18,083 Hectares (180 sq …
CHO Plus Selected for 2025 BioTools Innovator Accelerator Program
GlobeNewswire
·
June 17, 2025
SOUTH SAN FRANCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Privately-held CHO Plus, Inc., a leading developer of biopharmaceutical manufacturing technology, announced its selection for the 2025 BioTools Innovator Accelerator, the first and only program …
Ashvattha Therapeutics to Present Data on Novel Nanomedicine Radiotracers at SNMMI Annual Meeting
GlobeNewswire
·
June 17, 2025
REDWOOD CITY, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in …
ORYZON to Attend the 2025 Phelan-McDermid Syndrome (PMS) Congress in Barcelona on June 26-29
GlobeNewswire
·
June 17, 2025
Oryzon’s CSO, Dr. Jordi Xaus, will participate in a Panel entitled “Industry Perspectives Discussion” on June 27 70-90% of PMS patients show autistic related features, including aggression Agitation/Aggression in PMS and other ASD-related patient …
Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development
GlobeNewswire
·
June 17, 2025
Expanded alliance combines Lisata’s drug development expertise with GATC’s AI-powered Multiomics Advanced Technology® platform to accelerate and improve success rates of next-generation drug development Lisata to lead development efforts to advance GATC’s …
Midland en partenariat avec SOQUEM débute son programme d’exploration 2025 dans un secteur stratégique de la Fosse du Labrador, Québec
GlobeNewswire
·
June 17, 2025
MONTRÉAL, 17 juin 2025 (GLOBE NEWSWIRE) -- Exploration Midland inc. (« Midland ») (TSX-V : MD) a le plaisir de présenter son programme d’exploration pour l’été 2025 dans le cadre de l’alliance stratégique (« l’Alliance ») avec SOQUEM inc. (« SOQUEM ») pour …
Midland in Partnership With SOQUEM Begins Its 2025 Exploration Program in a Strategic Part of the Labrador Trough, Quebec
GlobeNewswire
·
June 17, 2025
MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to present its summer 2025 exploration program under the Strategic Alliance (the “Alliance”) with SOQUEM Inc. (“SOQUEM”) focusing on exploration in the …
TDG Gold Announces Acquisition of Anyox Copper and C$25 Million Bought Deal Private Placement
GlobeNewswire
·
June 17, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES WHITE ROCK, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- TDG Gold Corp (TSXV: TDG, OTCQX:TDGGF) (the “Company” or “TDG”) is pleased to announce that it …
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
GlobeNewswire
·
June 17, 2025
CHASKA, Minn., June 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has signed a new 10-year commercial …
Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide
GlobeNewswire
·
June 17, 2025
BOSTON and SHANGHAI, June 17, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced that …
Tisento Therapeutics Receives U.S. FDA Fast Track Designation for Zagociguat for the Treatment of MELAS
GlobeNewswire
·
June 17, 2025
CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to zagociguat for the treatment of MELAS (Mitochondrial Encephalomyopathy, Lactic …
Koryx Copper Provides Project Development Update for the Haib Copper Project, Southern Namibia
GlobeNewswire
·
June 17, 2025
Highlights Metallurgical testwork program with encouraging preliminary results including 89% average flotation recovery from 120-150µm grind size producing clean concentrate with grade of 20-25% Cu. Pre-concentration and heap leach testwork ongoing with …
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
GlobeNewswire
·
June 17, 2025
The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF and plasma exposures reinforce VTX3232’s potential as a once-daily oral therapy for neurodegenerative diseases VTX3232 …
Material Update on Off-Market Takeover by Bastion Mining
GlobeNewswire
·
June 17, 2025
TORONTO, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) today provides an important update in relation to the off-market takeover offer by Bastion Mining Pte. Ltd. UEN 202512367N (Bastion) to acquire …
Surge Copper Reports Excellent Metallurgical Results Supporting Pre-Feasibility Advancement at Berg Project
GlobeNewswire
·
June 17, 2025
Locked cycle tests exceed 90% copper and molybdenum recoveries and confirm clean final products with high separation efficiency Vancouver, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) …
NexGold Receives Notice of Completion on Industrial Approval from the Government of Nova Scotia for the Goldboro Gold Project
GlobeNewswire
·
June 17, 2025
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce that the Government of Nova Scotia has deemed the Company’s application for an Industrial Approval of a Surface …
OROCO ANNOUNCES PRIVATE PLACEMENT
GlobeNewswire
·
June 17, 2025
VANCOUVER, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce a non-brokered private placement (the “Offering”) of up to 5,000,000 units of the Company (each, a “Unit”) …
Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma
GlobeNewswire
·
June 17, 2025
LYL314 demonstrated robust clinical responses, with an 88% overall response rate and a 72% complete response rate in patients treated in the third- or later-line setting (N = 25) 71% of patients with complete response remained in complete response at ≥ 6 …
Prime Announces Completion of June Warrant Exercise
GlobeNewswire
·
June 17, 2025
VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) announces that 97% of its $1.10 warrants due June 12, 2025 have been exercised, which, including the …
Astrocyte Pharmaceuticals Announces Milestones in the Fight Against Concussions: Launch of Phase 2 Clinical Trial and New $3M NIH Grant
GlobeNewswire
·
June 17, 2025
GROTON, Conn., June 17, 2025 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc., a clinical-stage biotechnology company today announced two major milestones that could change the way we protect brains from the damage caused by concussions and repeat head …